Ovarian Follicular Development During the Use of Oral Contraception: A Review
References (80)
- et al.
Fertility control with oral medication
Am J Obstet Gynecol
(1958) - et al.
Pituitary response to LHRH stimulation in women on oral contraceptives: a follow up dose response study
Contraception
(1981) - et al.
Effects of Progestin-estrogen combination and progestational contraceptives on pituitary gonadotropins, gonadal steroids and sex hormone-binding globulin
Fertil Steril
(1980) - et al.
Neuroendocrine mechanism of anovulation in users of contraceptive subdermal implant of nomegestrel acetate (uniplant)
Fertil Steril
(1997) - et al.
Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial
Contraception
(2003) - et al.
Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial
Obstet Gynecol
(2003) - et al.
Effect of age on the response of the hypothalamo-pituitary-ovarian axis to a combined oral contraceptive
Fertil Steril
(1999) - et al.
Ovarian follicular development in oral contraceptive cycles
Fertil Steril
(1987) - et al.
Longitudinal ultrasonograPhic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect pill intake
Am J Obstet Gynecol
(1989) Ovarian follicles during oral contraceptive cycles: their potential for ovulation
Fertil Steril
(1989)
A randomized, double-blind, placebo-controlled comparison of the impact of low-dose and triphasic oral contraceptives on follicular development
Am J Obstet Gynecol
Enlarged follicles in women using oral contraceptives
Contraception
Ovarian function during low-dose oral contraceptive use
Contraception
Ovarian activity during regular oral contraceptive use
Contraception
Inhibition of ovulation by an oral contraceptive containing 100 mcg levonorgestrel in combination with 20 mcg ethiny; estradiol
Contraception
SGiA:Ortho EVRATM vs oral contraceptives: follicular development and ovulation in normal cycles and after an intentional dosing error
Fertil Steril
A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels
Contraception
Effect of two oral contraceptives containing 30 micrograms ethinylestradiol and 75 micrograms gestodene or 150 micrograms desogestrel upon various hormonal parameters
Contraception
Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel
Contraception
Ultrasound evaluation of ovarian activity under oral contraceptives
Contraception
Mean versus individual hormonal profiles in the menstrual cycle
Fertil Steril
Studies on low dose oral contraceptives: Plasma hormone changes in relation to deliberate pill (′microgynon 30‵) omission
Contraception
Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive
Am J Obstet Gynecol
Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives
Contraception
Oral contraceptive type and functional ovarian cysts
Am Obstet Gynecol
“Sunday start” multiphasic oral contraception: ovulation prevention and delayed follicular atresia in primates
Contraception
Predicting risk of ovulation in new start oral contraceptive users
Obstet Gynecol
Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation
Am J Obstet Gynecol
Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity
Fertil Steril
Shorter pill-free interval in combined oral contraceptives decreases follicular development
Contraception
Ovarian activity in women taking an oral contraceptive containing 20 microg ethinyl estradiol and 150 microg desogestrel: effects of low estrogen doses during the hormone-free interval
Am J Obstet Gynecol
′Escape‵ ovulation in women due to the missing of low dose combination oral contraceptive pills
Contraception
Hormonal consequences of “missing the Pill”
Contraception
The effect of deliberate omission of trinordiol or microgynon on the hypothalamo-pituitary-ovarian axis
Contraception
The effect of follicular growth and luteal function of “missing the pill” A comparison between a monophasic and a triphasic combined oral contraceptive
Contraception
The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol
Contraception
Single monthly administration of the anti-Progestagen org 31710 in users of the 75 microg desogestrel progestagen-only Pill: effects on pituitary-ovarian activity
Hum Reprod
Early folliculogenesis in primate ovaries: testing the role of estrogen
Biol Reprod
Early follicle growth in the juvenile macaca monkey ovary: the effects of estrogen priming and follicle-stimulating hormone
Biol Reprod
Managing contraceptive pill patients
Cited by (40)
Contraceptive-specific antimüllerian hormone values in reproductive-age women: a population study of 42,684 women
2023, Fertility and SterilityContinuous body temperature as a window into adolescent development
2023, Developmental Cognitive NeuroscienceHormone-based models for comparing menstrual cycle and hormonal contraceptive effects on human resting-state functional connectivity
2022, Frontiers in NeuroendocrinologyOvarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review
2016, Reproductive BioMedicine OnlineCitation Excerpt :In the last 50 years, the composition of hormonal contraceptives has undergone several modifications in order to reduce as much as possible the side effects, and to increase the compliance of women, while preserving contraceptive efficacy. Scientific literature shows that reducing the dose of oestrogen of combined contraceptives, to minimize its adverse effects, is associated with a decrease in pituitary gonadotrophin secretion, particularly during the hormone-free interval (HFI) or following missed doses, resulting in greater follicular development (Baerwald and Pierson, 2004). In this regard, several studies have evaluated the residual ovarian function during treatment with hormonal contraceptives, comparing different doses of steroids, duration of the HFI, and administration schemes.
Effects of gonadotropin on Fas and/or FasL expression and proliferation in rat ovary
2015, TheriogenologyCitation Excerpt :The mammalian ovarian life span is determined at the time of birth through a delicate balance of ovarian cell survival and apoptosis, and only 1% of primordial follicles are selected to ovulate during the ovarian cycle throughout the life span [1–3].
- *
Dr Pierson has received grants from Janssen-Ortho Inc. Organon NV, RW Johnson Pharmaceutical Research Institute and Ares-Serono and funding from the Canadian Institutes of Health Research.